constipation

News

Grünenthal's chief executive Gabriel Baertschi

Grünenthal buys Valinor and constipation drug for $250m

German pain medicines specialist Grünenthal has dipped another toe in the M&A waters with a $250 million agreement to buy US drugmaker Valinor Pharma.

News

Bruce T. Martin Photography
508-655-7557
btm@brucetmartin.com
154 East Central St
Natick MA 01760

FDA advisers back Shire constipation drug

Shire’s constipation drug prucalopride is moving closer to market – advisers to the FDA have just unanimously backed it as a treatment for chronic idiopathic constipation (CIC) in adults.

News

Valeant constipation drug approved in US

FDA panel also recommends Valeant's psoriasis medicine.

Grünenthal buys Valinor and constipation drug for $250m

FDA advisers back Shire constipation drug

Valeant constipation drug approved in US

Chiesi signs $1.9bn deal to buy KalVista and its HAE drug

Using AI-driven synthetic personas to take your insights fur...

Editor's Picks